Toll Free: 1-888-928-9744
Published: Aug, 2018 | Pages:
100 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report focuses on the global Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Cell Lung Cancer Therapeutics development in United States, Europe and China. Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second hand smoking, or on exposure to asbestos, chromium, arsenic, nickel, soot, or radon. The common symptoms associated with lung cancer are chest pain, incurable cough, blood in sputum, fatigue, loss of appetite, unintentional weight loss, shortness of breath, and wheezing. Small cell lung cancer has a poor prognosis and gets diagnosed only at the late stage of disease progression, and hence, has a high mortality rate. There are no therapies available to cure small cell lung cancer in the market. In 2017, the global Small Cell Lung Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Sanofi Bristol-Myers Squibb GlaxoSmithKline Menarini Ziopharm Oncology Merck Novartis AstraZeneca Takeda Pharmaceutical Teva Pharmaceutical Eli Lilly Mylan Sun Pharmaceuticals Industries Amgen Ono Pharmaceutical Shanghai Jinhe Bio-Technology Market segment by Type, the product can be split into Biologics Small molecules Market segment by Application, split into Hospitals Clinics Other Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. To present the Small Cell Lung Cancer Therapeutics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Small Cell Lung Cancer Therapeutics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (2013-2025) 1.4.2 Biologics 1.4.3 Small molecules 1.5 Market by Application 1.5.1 Global Small Cell Lung Cancer Therapeutics Market Share by Application (2013-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Small Cell Lung Cancer Therapeutics Market Size 2.2 Small Cell Lung Cancer Therapeutics Growth Trends by Regions 2.2.1 Small Cell Lung Cancer Therapeutics Market Size by Regions (2013-2025) 2.2.2 Small Cell Lung Cancer Therapeutics Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Small Cell Lung Cancer Therapeutics Market Size by Manufacturers 3.1.1 Global Small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2013-2018) 3.1.2 Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served 3.3 Key Players Small Cell Lung Cancer Therapeutics Product/Solution/Service 3.4 Date of Enter into Small Cell Lung Cancer Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) 4.2 Global Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) 5 United States 5.1 United States Small Cell Lung Cancer Therapeutics Market Size (2013-2018) 5.2 Small Cell Lung Cancer Therapeutics Key Players in United States 5.3 United States Small Cell Lung Cancer Therapeutics Market Size by Type 5.4 United States Small Cell Lung Cancer Therapeutics Market Size by Application 6 Europe 6.1 Europe Small Cell Lung Cancer Therapeutics Market Size (2013-2018) 6.2 Small Cell Lung Cancer Therapeutics Key Players in Europe 6.3 Europe Small Cell Lung Cancer Therapeutics Market Size by Type 6.4 Europe Small Cell Lung Cancer Therapeutics Market Size by Application 7 China 7.1 China Small Cell Lung Cancer Therapeutics Market Size (2013-2018) 7.2 Small Cell Lung Cancer Therapeutics Key Players in China 7.3 China Small Cell Lung Cancer Therapeutics Market Size by Type 7.4 China Small Cell Lung Cancer Therapeutics Market Size by Application 8 Japan 8.1 Japan Small Cell Lung Cancer Therapeutics Market Size (2013-2018) 8.2 Small Cell Lung Cancer Therapeutics Key Players in Japan 8.3 Japan Small Cell Lung Cancer Therapeutics Market Size by Type 8.4 Japan Small Cell Lung Cancer Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size (2013-2018) 9.2 Small Cell Lung Cancer Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Type 9.4 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Application 10 India 10.1 India Small Cell Lung Cancer Therapeutics Market Size (2013-2018) 10.2 Small Cell Lung Cancer Therapeutics Key Players in India 10.3 India Small Cell Lung Cancer Therapeutics Market Size by Type 10.4 India Small Cell Lung Cancer Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Small Cell Lung Cancer Therapeutics Market Size (2013-2018) 11.2 Small Cell Lung Cancer Therapeutics Key Players in Central & South America 11.3 Central & South America Small Cell Lung Cancer Therapeutics Market Size by Type 11.4 Central & South America Small Cell Lung Cancer Therapeutics Market Size by Application 12 International Players Profiles 12.1 Sanofi 12.1.1 Sanofi Company Details 12.1.2 Company Description and Business Overview 12.1.3 Small Cell Lung Cancer Therapeutics Introduction 12.1.4 Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.1.5 Sanofi Recent Development 12.2 Bristol-Myers Squibb 12.2.1 Bristol-Myers Squibb Company Details 12.2.2 Company Description and Business Overview 12.2.3 Small Cell Lung Cancer Therapeutics Introduction 12.2.4 Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.2.5 Bristol-Myers Squibb Recent Development 12.3 GlaxoSmithKline 12.3.1 GlaxoSmithKline Company Details 12.3.2 Company Description and Business Overview 12.3.3 Small Cell Lung Cancer Therapeutics Introduction 12.3.4 GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.3.5 GlaxoSmithKline Recent Development 12.4 Menarini 12.4.1 Menarini Company Details 12.4.2 Company Description and Business Overview 12.4.3 Small Cell Lung Cancer Therapeutics Introduction 12.4.4 Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.4.5 Menarini Recent Development 12.5 Ziopharm Oncology 12.5.1 Ziopharm Oncology Company Details 12.5.2 Company Description and Business Overview 12.5.3 Small Cell Lung Cancer Therapeutics Introduction 12.5.4 Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.5.5 Ziopharm Oncology Recent Development 12.6 Merck 12.6.1 Merck Company Details 12.6.2 Company Description and Business Overview 12.6.3 Small Cell Lung Cancer Therapeutics Introduction 12.6.4 Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.6.5 Merck Recent Development 12.7 Novartis 12.7.1 Novartis Company Details 12.7.2 Company Description and Business Overview 12.7.3 Small Cell Lung Cancer Therapeutics Introduction 12.7.4 Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.7.5 Novartis Recent Development 12.8 AstraZeneca 12.8.1 AstraZeneca Company Details 12.8.2 Company Description and Business Overview 12.8.3 Small Cell Lung Cancer Therapeutics Introduction 12.8.4 AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.8.5 AstraZeneca Recent Development 12.9 Takeda Pharmaceutical 12.9.1 Takeda Pharmaceutical Company Details 12.9.2 Company Description and Business Overview 12.9.3 Small Cell Lung Cancer Therapeutics Introduction 12.9.4 Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.9.5 Takeda Pharmaceutical Recent Development 12.10 Teva Pharmaceutical 12.10.1 Teva Pharmaceutical Company Details 12.10.2 Company Description and Business Overview 12.10.3 Small Cell Lung Cancer Therapeutics Introduction 12.10.4 Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) 12.10.5 Teva Pharmaceutical Recent Development 12.11 Eli Lilly 12.12 Mylan 12.13 Sun Pharmaceuticals Industries 12.14 Amgen 12.15 Ono Pharmaceutical 12.16 Shanghai Jinhe Bio-Technology 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Small Cell Lung Cancer Therapeutics Key Market Segments Table Key Players Small Cell Lung Cancer Therapeutics Covered Table Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$) Figure Global Small Cell Lung Cancer Therapeutics Market Size Market Share by Type 2013-2025 Figure Biologics Figures Table Key Players of Biologics Figure Small molecules Figures Table Key Players of Small molecules Table Global Small Cell Lung Cancer Therapeutics Market Size Growth by Application 2013-2025 (Million US$) Figure Hospitals Case Studies Figure Clinics Case Studies Figure Other Case Studies Figure Small Cell Lung Cancer Therapeutics Report Years Considered Table Global Small Cell Lung Cancer Therapeutics Market Size 2013-2025 (Million US$) Figure Global Small Cell Lung Cancer Therapeutics Market Size and Growth Rate 2013-2025 (Million US$) Table Global Small Cell Lung Cancer Therapeutics Market Size by Regions 2013-2025 (Million US$) Table Global Small Cell Lung Cancer Therapeutics Market Size by Regions 2013-2018 (Million US$) Table Global Small Cell Lung Cancer Therapeutics Market Share by Regions 2013-2018 Figure Global Small Cell Lung Cancer Therapeutics Market Share by Regions 2013-2018 Figure Global Small Cell Lung Cancer Therapeutics Market Share by Regions 2018 Table Market Top Trends Table Global Small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2013-2018) (Million US$) Table Global Small Cell Lung Cancer Therapeutics Market Share by Manufacturers (2013-2018) Figure Global Small Cell Lung Cancer Therapeutics Market Share by Manufacturers in 2018 Table Global Small Cell Lung Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Small Cell Lung Cancer Therapeutics Product/Solution/Service Table Date of Enter into Small Cell Lung Cancer Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) (Million US$) Table Global Small Cell Lung Cancer Therapeutics Market Size Share by Type (2013-2018) Figure Global Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2013-2018) Table Global Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) (Million US$) Table Global Small Cell Lung Cancer Therapeutics Market Size Share by Application (2013-2018) Figure Global Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2013-2018) Figure Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Application in 2017 Figure United States Small Cell Lung Cancer Therapeutics Market Size 2013-2018 (Million US$) Table United States Key Players Small Cell Lung Cancer Therapeutics Revenue (2017-2018) (Million US$) Table United States Key Players Small Cell Lung Cancer Therapeutics Market Share (2017-2018) Table United States Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) (Million US$) Table United States Small Cell Lung Cancer Therapeutics Market Share by Type (2013-2018) Table United States Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) (Million US$) Table United States Small Cell Lung Cancer Therapeutics Market Share by Application (2013-2018) Figure Europe Small Cell Lung Cancer Therapeutics Market Size 2013-2018 (Million US$) Table Europe Key Players Small Cell Lung Cancer Therapeutics Revenue (2017-2018) (Million US$) Table Europe Key Players Small Cell Lung Cancer Therapeutics Market Share (2017-2018) Table Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) (Million US$) Table Europe Small Cell Lung Cancer Therapeutics Market Share by Type (2013-2018) Table Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) (Million US$) Table Europe Small Cell Lung Cancer Therapeutics Market Share by Application (2013-2018) Figure China Small Cell Lung Cancer Therapeutics Market Size 2013-2018 (Million US$) Table China Key Players Small Cell Lung Cancer Therapeutics Revenue (2017-2018) (Million US$) Table China Key Players Small Cell Lung Cancer Therapeutics Market Share (2017-2018) Table China Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) (Million US$) Table China Small Cell Lung Cancer Therapeutics Market Share by Type (2013-2018) Table China Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) (Million US$) Table China Small Cell Lung Cancer Therapeutics Market Share by Application (2013-2018) Figure Japan Small Cell Lung Cancer Therapeutics Market Size 2013-2018 (Million US$) Table Japan Key Players Small Cell Lung Cancer Therapeutics Revenue (2017-2018) (Million US$) Table Japan Key Players Small Cell Lung Cancer Therapeutics Market Share (2017-2018) Table Japan Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) (Million US$) Table Japan Small Cell Lung Cancer Therapeutics Market Share by Type (2013-2018) Table Japan Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) (Million US$) Table Japan Small Cell Lung Cancer Therapeutics Market Share by Application (2013-2018) Figure Southeast Asia Small Cell Lung Cancer Therapeutics Market Size 2013-2018 (Million US$) Table Southeast Asia Key Players Small Cell Lung Cancer Therapeutics Revenue (2017-2018) (Million US$) Table Southeast Asia Key Players Small Cell Lung Cancer Therapeutics Market Share (2017-2018) Table Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) (Million US$) Table Southeast Asia Small Cell Lung Cancer Therapeutics Market Share by Type (2013-2018) Table Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) (Million US$) Table Southeast Asia Small Cell Lung Cancer Therapeutics Market Share by Application (2013-2018) Figure India Small Cell Lung Cancer Therapeutics Market Size 2013-2018 (Million US$) Table India Key Players Small Cell Lung Cancer Therapeutics Revenue (2017-2018) (Million US$) Table India Key Players Small Cell Lung Cancer Therapeutics Market Share (2017-2018) Table India Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) (Million US$) Table India Small Cell Lung Cancer Therapeutics Market Share by Type (2013-2018) Table India Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) (Million US$) Table India Small Cell Lung Cancer Therapeutics Market Share by Application (2013-2018) Figure Central & South America Small Cell Lung Cancer Therapeutics Market Size 2013-2018 (Million US$) Table Central & South America Key Players Small Cell Lung Cancer Therapeutics Revenue (2017-2018) (Million US$) Table Central & South America Key Players Small Cell Lung Cancer Therapeutics Market Share (2017-2018) Table Central & South America Small Cell Lung Cancer Therapeutics Market Size by Type (2013-2018) (Million US$) Table Central & South America Small Cell Lung Cancer Therapeutics Market Share by Type (2013-2018) Table Central & South America Small Cell Lung Cancer Therapeutics Market Size by Application (2013-2018) (Million US$) Table Central & South America Small Cell Lung Cancer Therapeutics Market Share by Application (2013-2018) Table Sanofi Company Details Table Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018) (Million US$) Figure Sanofi Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table Sanofi Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table Bristol-Myers Squibb Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table GlaxoSmithKline Recent Development Table Menarini Company Details Table Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure Menarini Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table Menarini Recent Development Table Ziopharm Oncology Company Details Table Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure Ziopharm Oncology Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table Ziopharm Oncology Recent Development Table Merck Company Details Table Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure Merck Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table Merck Recent Development Table Novartis Company Details Table Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure Novartis Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table Novartis Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure AstraZeneca Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table AstraZeneca Recent Development Table Takeda Pharmaceutical Company Details Table Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure Takeda Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table Takeda Pharmaceutical Recent Development Table Teva Pharmaceutical Company Details Table Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2013-2018)(Million US$) Figure Teva Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2013-2018) Table Teva Pharmaceutical Recent Development Table Eli Lilly Company Details Table Mylan Company Details Table Sun Pharmaceuticals Industries Company Details Table Amgen Company Details Table Ono Pharmaceutical Company Details Table Shanghai Jinhe Bio-Technology Company Details Table Global Small Cell Lung Cancer Therapeutics Market Size by Regions (Million US$) 2018-2025 Figure Global Small Cell Lung Cancer Therapeutics Market Size Share by Regions (2018-2025) Figure Global Small Cell Lung Cancer Therapeutics Market Size Share by Regions in 2025 Figure United States Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD) Figure Europe Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD) Figure China Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD) Figure Japan Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD) Figure Southeast Asia Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD) Figure India Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD) Figure Central & South America Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD) Table Global Small Cell Lung Cancer Therapeutics Market Size by Product (2018-2025) (Million US$) Figure Global Small Cell Lung Cancer Therapeutics Market Size by Product (2018-2025) Figure Global Small Cell Lung Cancer Therapeutics Market Size by Product in 2025 Table Global Small Cell Lung Cancer Therapeutics Market Size by Application (2018-2025) (Million US$) Figure Global Small Cell Lung Cancer Therapeutics Market Size by Application (2018-2025) Figure Global Small Cell Lung Cancer Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.